In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

Dechra Pharmaceuticals PLC Balance Sheet Statement - Assets

As of 30 Jun 2021, The total current assets of Dechra Pharmaceuticals PLC (LSE:DPH) was around £392,200,000 which consisted of £118,400,000 of Cash, £149,500,000 of Inventory and £119,200,000 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in GBP

Cash
£118.4M
Current assets
£392.2M
Total assets
£1.21B

The latest balance sheet of Dechra Pharmaceuticals PLC also showed £87,000,000 of Property Plant Equipment and £236,100,000 of Good will. Also there were £474,100,000 of Intangible assets and £7,600,000 of Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were £1,214,100,000.

Dechra Pharmaceuticals PLC Balance Sheet Statement - Liabilities

DPH's latest annual results shows the balance sheet has £35,200,000 of Accounts Payable. Also there were no Short/Long term debt, £302,700,000 of Long term debt, £43,100,000 of Other Current liabilities and £155,800,000 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
£35.2M
Current liabilities
£155.8M
Total liabilities
£581.2M

As per the 30 Jun 2021's annual report of Dechra Pharmaceuticals PLC, the total liabilities were £581,200,000.

DPH Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of Dechra Pharmaceuticals PLC showed the total stock holder equity was £632,900,000 which consisted of £1,100,000 of Common stocks, £147,700,000 of Retained earnings and £72,500,000 of Other stock holder equity.

DPH Balance Sheet Statement History

Following table shows the history of balance sheet for Dechra Pharmaceuticals PLC (DPH).

30 Jun 202130 Jun 202030 Jun 201930 Jun 2018
Cash118.4M227.4M80.3M79.7M
Net Receivables119.2M97.3M103.8M79M
Inventory149.5M120.8M103.5M86.6M
Total Current Assets392.2M448.9M291.5M247.9M
Property Plant Equipment87M76.4M58.4M45.3M
Good Will236.1M253.8M245.7M229.3M
Intangible Assets474.1M432.3M429.4M474.4M
Other Assets7.6M8.8M6.4M9.9M
Deferred Long Term Asset Charges2M2.7M900k3.8M
Total Assets1.21B1.24B1.04B1.02B
Accounts Payable35.2M34.6M31.9M33M
Short/Long Term Debt-1.4M1.2M1.2M
Other Current Liabilities43.1M37.6M23.3M27M
Long Term Debt302.7M338.6M306.9M289.9M
Other Liabilities109.9M112.4M107.4M130.8M
Total Current Liabilities155.8M137.3M118.1M91.6M
Total Liabilities581.2M600.1M532.4M512.3M
Common Stock1.1M1.1M1M1M
Retained Earnings147.7M126.4M124.2M125.5M
Treasury Stock72.5M100.7M106M101.8M
Other Stockholder Equity72.5M100.7M106M102.2M
Total Stockholder Equity632.9M637.5M509.1M505M
Net Tangible Assets-77.3M-48.6M-166M-198.7M

Dechra Pharmaceuticals PLC (LSE:DPH) Balance Sheet Statement FAQ

1. How much Cash Dechra Pharmaceuticals PLC has on their balance sheet?

As of 30 Jun 2021, Dechra Pharmaceuticals PLC (LSE:DPH) has £118,400,000 of Cash.

2. What's the long term debt of Dechra Pharmaceuticals PLC?

As per the latest Balance sheet of Dechra Pharmaceuticals PLC (LSE:DPH), it has £302,700,000 of Long term debt.

3. How much share holder equity does Dechra Pharmaceuticals PLC has?

The Dechra Pharmaceuticals PLC (LSE:DPH)'s balance sheet shows that it has £632,900,000 of Total stock holder equity.